Medclair AB Statistics
Total Valuation
Medclair AB has a market cap or net worth of SEK 271.28 million. The enterprise value is 252.41 million.
| Market Cap | 271.28M |
| Enterprise Value | 252.41M |
Important Dates
The next estimated earnings date is Monday, November 2, 2026.
| Earnings Date | Nov 2, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Medclair AB has 91.65 million shares outstanding.
| Current Share Class | 91.65M |
| Shares Outstanding | 91.65M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 13.39% |
| Owned by Institutions (%) | 17.91% |
| Float | 64.49M |
Valuation Ratios
The trailing PE ratio is 183.42.
| PE Ratio | 183.42 |
| Forward PE | n/a |
| PS Ratio | 5.01 |
| PB Ratio | 3.45 |
| P/TBV Ratio | 6.16 |
| P/FCF Ratio | 201.69 |
| P/OCF Ratio | 189.04 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 36.37, with an EV/FCF ratio of 187.66.
| EV / Earnings | 170.66 |
| EV / Sales | 4.66 |
| EV / EBITDA | 36.37 |
| EV / EBIT | 117.84 |
| EV / FCF | 187.66 |
Financial Position
The company has a current ratio of 3.84
| Current Ratio | 3.84 |
| Quick Ratio | 2.38 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 10.60 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 3.61% |
| Return on Capital Employed (ROCE) | 2.72% |
| Weighted Average Cost of Capital (WACC) | 8.44% |
| Revenue Per Employee | 3.61M |
| Profits Per Employee | 98,600 |
| Employee Count | 15 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -4.52% in the last 52 weeks. The beta is 0.76, so Medclair AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.76 |
| 52-Week Price Change | -4.52% |
| 50-Day Moving Average | 2.84 |
| 200-Day Moving Average | 2.66 |
| Relative Strength Index (RSI) | 55.00 |
| Average Volume (20 Days) | 228,238 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medclair AB had revenue of SEK 54.13 million and earned 1.48 million in profits.
| Revenue | 54.13M |
| Gross Profit | 34.86M |
| Operating Income | 2.14M |
| Pretax Income | 1.48M |
| Net Income | 1.48M |
| EBITDA | 6.94M |
| EBIT | 2.14M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 18.87 million in cash and no debt, with a net cash position of 18.87 million or 0.21 per share.
| Cash & Cash Equivalents | 18.87M |
| Total Debt | n/a |
| Net Cash | 18.87M |
| Net Cash Per Share | 0.21 |
| Equity (Book Value) | 78.73M |
| Book Value Per Share | n/a |
| Working Capital | 38.71M |
Cash Flow
In the last 12 months, operating cash flow was 1.44 million and capital expenditures -90,000, giving a free cash flow of 1.35 million.
| Operating Cash Flow | 1.44M |
| Capital Expenditures | -90,000 |
| Depreciation & Amortization | 4.80M |
| Net Borrowing | n/a |
| Free Cash Flow | 1.35M |
| FCF Per Share | 0.01 |
Margins
Gross margin is 64.40%, with operating and profit margins of 3.96% and 2.73%.
| Gross Margin | 64.40% |
| Operating Margin | 3.96% |
| Pretax Margin | 2.73% |
| Profit Margin | 2.73% |
| EBITDA Margin | 12.82% |
| EBIT Margin | 3.96% |
| FCF Margin | 2.48% |
Dividends & Yields
Medclair AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 0.55% |
| FCF Yield | 0.50% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |